SUCCESSFUL COVID-19 PROPOSALS

Pikado BV is proud to have contributed to the rapid and successful MANCO application to the H2020 SC1-PHE-CORONAVIRUS-2020 call towards the development of monoclonal antibody-based treatment against COVID-19.

Pikado BV helped prepared the project proposal of the CARE consortium that has been selected for funding by the IMI JU. The project aims to deliver treatments for COVID-19 and future coronavirus outbreaks.

Pikado BV also provided its expert support for the successful preparation of the INATAC proposal funded by Health Holland. It will further advance innovative antibody therapies against COVID-19 in the form of nanobodies and heavy-chain human antibodies HCAb.